An RSV vaccine has been approved for people over 60. But what about young children?
- Written by: Allen Cheng, Professor of Infectious Diseases, Monash University
Ground Picture/ShutterstockThe Therapeutic Goods Administration (TGA) has approved a vaccine against respiratory syncytial virus (RSV) in Australia for the first time. The shot, called Arexvy and manufactured by GSK, will be available by prescription to adults over 60.
RSV is a contagious respiratory virus which causes an illness similar to...
Read more: An RSV vaccine has been approved for people over 60. But what about young children?
